This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Key oncologic pathways inhibited by Erinacine A: A perspective for its development as an anticancer molecule.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 160, 114332
Citation
Prasher, Parteek; Sharma, Mousmee; Sharma, Amit Kumar; Sharifi-Rad, Javad; Calina, Daniela; Hano, Christophe; Cho, William C. (2023). Key oncologic pathways inhibited by Erinacine A: A perspective for its development as an anticancer molecule.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 160, 114332. https://doi.org/10.1016/j.biopha.2023.114332